Hot penny stocks... don't get burned
   

News for Rigel Pharmaceuticals, Inc (RIGL)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
News for Rigel Pharmaceuticals Inc.  (RIGL) 
|
$ 23.55      -0.08 (-0.34%) Volume: 187.8 k 1:31 PM EDT Sep 8, 2008
Wed, Aug 27, 2008
7:30 AM Rigel to Present at Thomas Weisel Partners Healthcare Conference - PR Newswire
Tue, Aug 05, 2008
7:30 AM Rigel Announces Second Quarter 2008 Financial Results - PR Newswire
Thu, Jul 03, 2008
7:30 AM Rigel to Present at Collins Stewart Growth Conference - PR Newswire
Wed, Jun 18, 2008
7:30 AM Rigel to Present at Jefferies Healthcare Conference - PR Newswire
Thu, Jun 12, 2008
7:30 AM Rigel Initiates Two Phase 2b Clinical Trials of R788 in Rheumatoid Arthritis - PR Newswire
Thu, Jun 05, 2008
7:30 AM Rigel to Present at the Needham Biotechnology and Medical Technology Conference - PR Newswire
Tue, Jun 03, 2008
2:21 PM New Analyst Reports for PACCAR INC, LKQ CORP, MICROCHIP TECHNOLOGY INC, and RIGEL PHARMACEUTICALS INC - Marketwire
6:00 AM Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL - PR Newswire
Mon, Jun 02, 2008
5:10 PM Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma - PR Newswire
Thu, May 22, 2008
6:00 AM VentiRx Pharmaceuticals Appoints Dr. Elliott Grossbard to Board of Directors - PR Newswire
Tue, May 06, 2008
7:30 AM Rigel Announces First Quarter 2008 Financial Results - PR Newswire
Tue, Apr 29, 2008
7:30 AM Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies - PR Newswire
Tue, Apr 08, 2008
7:30 AM Rigel's R788 Shows Preclinical Activity in Type 1 Diabetes Model - PR Newswire
Thu, Mar 27, 2008
7:30 AM Rigel to Present at 8th Annual Fortis Bank Biotechnology Conference - PR Newswire
Thu, Mar 13, 2008
7:30 AM Rigel Announces Participation in Upcoming Investor and Partnering Conferences - PR Newswire
Tue, Feb 26, 2008
7:30 AM Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research - PR Newswire
Tue, Feb 12, 2008
7:30 AM Rigel Announces Fourth Quarter and Year End 2007 Financial Results - PR Newswire
Wed, Feb 06, 2008
7:30 AM Rigel to Present at BIO CEO & Investor Conference - PR Newswire
Thu, Jan 31, 2008
8:33 PM Rigel Announces Pricing of Public Offering of Common Stock - PR Newswire
Thu, Jan 24, 2008
4:14 PM Rigel Announces Offering of 4,000,000 Shares of Common Stock - PR Newswire
Tue, Jan 15, 2008
7:30 AM Rigel to Present Programs at Four Upcoming Scientific Conferences - PR Newswire
Wed, Jan 09, 2008
7:30 AM Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders - PR Newswire
Thu, Dec 13, 2007
7:30 AM Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study - PR Newswire
Thu, Dec 06, 2007
7:30 AM Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer - PR Newswire
Wed, Dec 05, 2007
7:30 AM Rigel Announces Presentations at the 2007 American Society of Hematology (ASH) Meeting - PR Newswire
  Page 1 of 2   Next Page

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for RIGL stock. Download RIGL report.
Research Report
Get the full report for FREE
Date:Sep 3, 2008
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download RIGL report
  
Example preview: Research report for Rigel Pharmaceuticals, Inc (RIGL) Research report for Rigel Pharmaceuticals, Inc (RIGL) Research report for Rigel Pharmaceuticals, Inc (RIGL) Research report for Rigel Pharmaceuticals, Inc (RIGL)
   
   
   
Attention: Please help us to improve our services by answering the following poll:



Please Leave a comment to tell us how you think we can improve our services.

Your message:
   
   
   
   
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments
   
   
   
   

SPKL shot up 21%


From: OTC Journal
Added: 22 Sep, 2007

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Rigel Pharmaceuticals, Inc
Home | Message boards | Newsletters | Latest Comments | VC directory | AIM London Stock Exchange | Canadian stocks | Chinese stocks | Broker Directory
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2008 hotstocked.com - All rights reserved.